Background: Patients at low risk for acute coronary syndrome are frequently admitted for observation and
shorter in the CPC arm and the mean number of tests was lower in the CPC arm (decrease in 19.4 imaging studies per 100 patients, 95% CI = 15.5-23.3). When evaluating the entire encounter and follow-up period, the intervention arm underwent fewer tests (decrease in 125.6 tests per 100 patients, 95% CI = 29.3-221.6). More specifically, there were fewer advanced cardiac imaging tests completed (25.8 fewer per 100 patients, 95% CI = 3.74-47.9) in the intervention arm.
Conclusions: Shared decision making in low-risk chest pain can lead to decreased diagnostic testing without worsening outcomes measured over 45 days. C hest pain is the second most common reason patients visit emergency departments (EDs) across the United States, accounting for over 6 million visits annually. 1 Failure to diagnose acute coronary syndrome (ACS) can result in morbidity and mortality, causing clinicians to have a low threshold for admitting patients with chest pain for extensive cardiac testing. 2 Chest pain accounts for over 25% of all hospital admissions, yet over 85% of patients admitted for chest pain are not ultimately diagnosed with ACS. 3 To right-size testing to match both disease risk and informed patient preferences, we developed and tested a patient decision aid, Chest Pain Choice (CPC), to engage patients with symptoms potentially compatible with ACS in decisions regarding testing and followup. 4 CPC is a one-page decision aid that includes personalized and validated 45-day risk estimates for ACS 5, 6 and communicates this risk estimate to patients using a pictograph, natural frequencies with a common denominator, and simple prose language. 4, 7 CPC makes explicit the available management options to patients-to be admitted to the ED observation unit for cardiac stress testing or coronary computed tomography angiography (CCTA) or to follow-up with a cardiologist or the patient's primary care provider within 72 hours for further evaluation-and encourages them to engage with their clinician in selecting among these options.
In both our single center pilot trial 8 and our pragmatic multicenter trial, 4 we found that patients assigned to CPC were less often admitted to the ED observation unit for cardiac stress testing or CCTA. We also observed a lower rate of stress testing within 30 days in the intervention group. In prior studies, we reported only the initial conjoined patient and clinician decision and the rates of cardiac investigations (stress testing, CCTA) and interventions (coronary angiography, percutaneous coronary intervention, or coronary artery bypass grafting). We did not previously assess other components of health care utilization such as follow-up visits, laboratory testing, and physician billing codes. The purpose of this investigation was to measure the effect of CPC on health care utilization both during the index ED visit and in the subsequent 45 days.
METHODS

Study Design
The background and methods of the trial are described in detail elsewhere. 7 Briefly, the CPC trial was a pragmatic parallel randomized controlled trial 9 in low-risk patients presenting to the ED with a potential ACS. The trial compared an intervention group receiving a structured risk assessment using a quantitative pretest probability Web tool and corresponding decision aid to a control group receiving usual care (UC). The institutional review boards at each of the participating hospitals approved all study procedures.
Study Setting and Population
Patients and clinicians were enrolled from the EDs at six U.S. medical centers (University of California Davis on the West Coast, Mayo Clinic Rochester and Indiana University in the Midwest, University of Pennsylvania and Thomas Jefferson University on the East Coast, and Mayo Clinic Florida in the Southeast). Eligible clinicians included all physicians, nurse practitioners, and physician assistants caring for patients with chest pain. Eligible patients included adults (>17 years of age) presenting to the ED with a chief complaint of chest pain who were being considered by the treating clinician for observation unit admission for cardiac stress testing or CCTA. Patients were excluded if they had ischemic changes on the initial electrocardiogram (ECG; e.g., ST-segment depression, T-wave inversions, or new left bundle branch block), initial cardiac troponin > 99 th percentile, known coronary artery disease, cocaine use in the past 72 hours (by history or testing), prior plan for cardiac intervention or admission, identification of the enrolling institution not being the patient's primary institution for care, barriers to outpatient follow-up, prisoners, pregnancy, or patients who were hearing or visually impaired or otherwise unable to use the decision aid. Patients deemed to meet exclusion criteria after randomization, but before the patient-clinician disposition discussion, were classified as postrandomization exclusions. 10 
Study Protocol
Patients were randomized 1:1 to either CPC or UC and dynamically stratified 11 by age, sex, and site. For patients randomized to CPC, the 45-day risk for ACS was estimated 5 and a decision aid corresponding to the appropriate level of risk was provided to the clinician. The treating clinician, after evaluating the patient and the results of the initial ECG and cardiac troponin were available, used the decision aid to educate the patient regarding the results of the initial cardiac troponin and ECG, the potential need for observation and further cardiac testing, and the patient's personalized 45-day risk for ACS. The clinician then engaged the patient in selecting the management option most closely aligned with his/her values and preferences. For patients randomized to UC, a research associate instructed the clinician to discuss the results of diagnostic investigations and management options per that clinician's usual fashion. As the trial was intentionally pragmatic in design, UC was not standardized. 12 
Data Collection
Data documenting the screening process, randomization, and outcome assessment were collected in compliance with CONSORT guidelines.
13
Study coordinators contacted patients starting at 45 days after enrollment to assess utilization. Study coordinators made at least five attempts to contact patients by phone for follow-up during different times of the day and on different days of the week. If the patient was unable to be reached by phone or e-mail and no subsequent visits in the electronic medical record were documented, mortality status was verified using Accurint, a national database frequently used by banks and other businesses to track individuals and ensure payment collection.
14 Patient utilization data were collected using two separate methods to ensure that we had the most complete data for each patient. First, each site provided all the billing data for each of the enrolled patients for the initial visit and the 45 days after the initial visit. Second, each patient filled out a diary documenting their utilization in the 45 days after the ED visit. Patients were queried regarding this diary and any additional testing, outpatient or inpatient visits, or procedures at health care facilities not at the original institution during the 45-day phone call. Using these complementary approaches, we were able to obtain a more comprehensive view of health care utilization. ED and observation unit length of stay (LOS) for the index visit were analyzed from the original data set.
Key Outcome Measures
Our outcomes were use of health care services including length of time in the ED and observation unit, ED visits, office visits, hospitalizations, testing, imaging, and procedures using both hospital-level billing data and patient reported data. We assessed the amount of time (in minutes) spent in the ED and ED observation unit in each of the arms during the index visit. The billing data provided information on testing, imaging, visits, procedures, and other utilization during the initial visit and in the following 45 days. Although we initially planned to assess 30-day health care utilization in our study protocol, 7 we had collected billing data up to 45 days and chose to include health care utilization for these additional 15 days to increase the robustness of the analysis. All utilization from the billing data was classified using the Berenson-Eggers Types of Service (BETOS) codes. 15 "Testing" in this classification includes laboratory testing, ECG and ECG monitoring, and stress testing; "imaging" includes all plain x-ray, advanced imaging, and ultrasound including non-stress cardiac ultrasounds. Tests were further subcategorized to assess for differences between the intervention and control groups according to individual test types. Although we did not prespecify a primary outcome among the various components of health care utilization, we hypothesized that we would most likely see a lower rate of testing in the intervention arm as the decision aid specifically addressed the need for subsequent cardiac testing after ruling out for acute myocardial infarction. Patient-reported data provided information on subsequent hospitalizations, ED visits, physician office visits, the number of visits for each, and testing during those visits. The Affordable Care Act legislation that led to the formation of the Patient Centered Outcomes Research Institute, which funded the primary trial, 4 did not allow collection of data and publication of that data around costs of medical care. For this reason, we report the data in terms of utilization.
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Data Analysis
We summarized patient characteristics by study group and tested for differences in billing based and selfreported utilization between groups using t-tests, chisquare tests, and Kruskal-Wallis tests, as appropriate. To test for differences in outcomes, we estimated a series of regression models, each of which included indicators for study group. We used appropriate count data models for each of the utilization outcomes. For outcomes that had less than 10% of the patients with zero utilization, we used Poisson or negative binomial models depending on the extent of overdispersion. Among outcomes with over 10% of patients with no utilization, we used a two-part model, sometimes referred to as a hurdle model, which separates the utilization outcomes into two distinct parts: whether there was any utilization of that service and the amount of utilization of that service conditional on any utilization. More specifically, the first hurdle used a logistic model to estimate the relative odds of having any utilization for a type of service, while the second part used Poisson models to estimate the extent of utilization. All analyses were conducted for the utilization during the index ED visit, utilization in the 45 days after the index visit, and total utilization. To account for potential nonindependence of outcomes by site, we adjusted for study site in each model. We assessed for additional correlation within clinicians by estimating a hierarchical generalized model for each outcome and calculating the intraclinician correlation (ICC). All ICCs were less than 1%, so we chose not to account for this correlation in the final models.
RESULTS
There were 913 patients randomized in the original trial with 13 postrandomization exclusions and two patients who withdrew consent. Table 1 presents the descriptive characteristics for the trial population. There were no significant differences in age, sex, cardiovascular risk factors, chest pain duration, or pretest probability of ACS between study arms.
Billing-based Utilization
Hospital-level billing data were available for all 898 (100%) enrolled patients. Overall, including the date of the ED visit and the subsequent 45 days, there was no difference in physician evaluation and management codes (level of physician services), number of imaging tests obtained, or the number of procedures performed between arms of the study (Table 2) . During the index ED visit, the mean number of imaging studies was lower in the CPC arm (decrease in 19.4 imaging studies per 100 patients, 95% confidence interval [CI] = 15.5-23.3). In the 45 days following the ED visit (not including the ED visit), patients randomized to CPC underwent fewer tests overall (decrease in 125.6 tests per 100 patients, 95% CI 29.3-221.6; Table 2 ). When these groups were categorized together, fewer advanced cardiac imaging tests (including CCTA, stress echocardiography, resting echocardiography, myocardial perfusion imaging, cardiac MRI, and myocardial positron emission tomography) were completed in the CPC arm (decrease in 25.8 these tests per 100 patients, 95% CI = 3.74-47.9; Table 3 ).
Patient-reported Utilization
Of the 898 analyzed patients, patient-reported health care utilization data were available for all 834 (92.9%) patients who were reached by phone for 45-day follow- Data are presented as mean (AESD) or n (%). ACS = acute coronary syndrome; UC = usual care. *Unless otherwise specified.
up. Based on the eight patient-reported utilization questions in the health care diary, there were no significant differences in 45-day health care utilization between the study arms (Table 4) . We conducted a sensitivity analysis assuming a negative outcome for those lost to follow-up and found no difference in the results of the analysis.
LOS (Index Visit)
There was no difference in the median ED LOS during the index visit. There was also no difference in the frequency of observation unit admission between arms. However, for those patients who were admitted to the ED observation unit, the median LOS was 95 minutes shorter in the CPC arm (824.8 minutes CPC vs. 920.2 minutes UC; 95% CI = 40.8-149.8; Table 5 ).
DISCUSSION
Main Study Findings
Findings from this trial suggest that using CPC can lead to a decreased number of tests in a low-risk chest pain population over the subsequent 45 days. Specifically, we showed a decrease of 25.8 advanced cardiac imaging tests per 100 patients. This finding complements our previous observations that patients who were engaged in shared decision making had a lower rate of imaging during the index ED visit. 8 CPC had no effect on ED LOS or the proportion of patients admitted to an observation unit,. However, CPC patients had an observation unit LOS that, on average, was shorter by 90 minutes. It is not entirely clear how using CPC led to this finding; however, it is possible that increased patient knowledge and engagement and decreased decisional conflict in the CPC group 4 could be responsible for improved efficiencies through the observation period. The nature of the reduced testing includes laboratory, ECG, stress testing, ECG monitoring, and other testing not including imaging or procedures. We found no difference when analyzing patient reported ED use, primary care, hospital visits, or testing.
When comparing utilization between the two arms of the study, we believe that any differences observed would be derived mainly from the observation period. This is because enrollment in the study occurred after the initial ECG, imaging as appropriate to exclude actionable causes of the patient's symptoms, and the initial cardiac troponin and other blood chemistry Table 2 Health results were available and therefore should not impact the ED phase of the workup. Most importantly, the data from this trial show that CPC can have a durable effect on diagnostic testing, lasting 45 days following the initial ED encounter. And, as we combine these results with our previous findings, this can be Data are presented as n (%) unless otherwise specified. UC = usual care.
accomplished without worsening outcomes 4 or appreciably increasing LOS in the ED. These data provide further evidence that health care utilization can decrease when patients are empowered with a better understanding of their risk and involved in choices made regarding their care.
Strengths and Weaknesses of the Study
Health care utilization measures were defined prospectively as secondary outcomes that would be evaluated. However, the study design was not powered to detect a difference in these measures. 7 Although trained personnel reviewed medical records and attempted to contact all enrolled patients, we were unable to contact 70 (8%) patients. As such, we were unable to collect patient-reported utilization data in these patients. Hospital-level billing data, however, were available in 100% of the enrolled patients. Although it is possible that patients could have undergone further testing outside of these institutions, all of the patients identified the institution where they were enrolled as their primary institution and our 92% phone follow-up rates suggests that this is not likely to be the case. The different results between billing data and patient data may be due to differences in the categorization between the two methods: patient-reported utilization grouped all forms of testing including imaging and procedures. This could also be explained by recall bias. For these reasons, our results should be interpreted with some caution. However, it should also be noted that in none of the analyses was testing or health care utilization increased in the shared decision making group.
Comparison to Other Studies
To the best of our knowledge, this is the first multicenter trial evaluating a shared decision making model in the ED and its impact on utilization during the ED visit or observation unit stay and within 45 days of the index visit. In this study, we observed a decrease in diagnostic testing associated with the use of CPC. This finding is consistent with a previous yet smaller study completed at a single institution. 8 Several other studies suggest that shared decision making has potential to decrease utilization. [16] [17] [18] [19] These empiric data add to this knowledge base to further the practice of patient centered care and shared decision making in the acute setting.
CONCLUSION
Shared decision making in low-risk chest pain can lead to decreased diagnostic testing without worsening outcomes at 45 days. Although this observation may not be consistently observed across shared decision making studies depending on the disease entity being studied and the appropriateness of utilization in usual practice, informing and engaging patients in diagnostic care decisions has potential to right-size testing to disease risk. 
